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Pharmacist prescribing (PP) has been 
implemented successfully in different 
countries.
Developments are supported by evidence of 
effectiveness and safety.
To facilitate further development, there is a 
need to review the evidence of views and 
experiences of stakeholder groups.
To critically appraise, synthesise and present 
the available evidence on the views and 
experiences of stakeholders pre- and post-
implementation of PP globally as well as 
explore potential facilitators and barriers of 
this new role
Description of studies included:
There were 64 articles included (Figure 1).
The UK was the main country studied.
The majority of papers investigated 
perceptions and views of pharmacists post-
implementation.
Quality of included reviews:
Quantitative studies mainly had issues 
relating to sampling, questionnaire 
development and response rate.
Some qualitative studies did not take the 
context and researcher’s influences into 
consideration.
The only issue with mixed-method studies 
was not considering the limitations of 
integrating quantitative and qualitative data.
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Results
Figure 1: PRISMA flow chart for inclusion process
Stakeholders’ views and experience with PP:
Regardless of implementation status, PP was 
positively viewed by majority of stakeholders.
Benefits of this role include improved access 
to healthcare, better use of pharmacist’s skills 
and improved patient consultations.
Some stakeholders expressed concerns over 
pharmacists’ clinical expertise and access to 
medical records, medical resistance as well as 
legal implications of such role.
Facilitators and barriers to PP:
More in-depth research is needed to further 
investigate the different stakeholders’ 
perceptions and experiences with PP.
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